# Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)

> **NCT00279344** · PHASE3 · COMPLETED · sponsor: **Nycomed** · enrollment: 220 (—)

## Conditions studied

- Standard Opioid Analgesic Treatment of Cancer-related Chronic Pain.

## Interventions

- **DRUG:** Fentanyl (Matrifen)

## Key facts

- **NCT ID:** NCT00279344
- **Lead sponsor:** Nycomed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2007-08
- **Target enrollment:** 220 (—)
- **Last updated:** 2012-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00279344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00279344, "Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00279344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*